News

Category:
|
August 13, 2020

Dewpoint featured in Business Insiders list of biotech start-ups set to take off

We are proud to have been featured by Business Insider as one of 21 start-ups considered by top biotech venture capital investors to be poised to take off in the next 12 months. 

Read more on businessinsider.com

Media Contact

Jeanette Bressi
VP, Head of Communications & PR
Dewpoint Therapeutics
+1 609-439-3997 | jbressi@dewpointx.com

Investor Contact

Scott Peterson, Ph.D.
SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science